Ignite Creation Date:
2024-07-17 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06472570
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-05-21
Brief Title:
Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
Sponsor:
Maria Sklodowska-Curie National Research Institute of Oncology
Organization:
Maria Sklodowska-Curie National Research Institute of Oncology
Study Overview
Official Title:
Escalating a Biological Dose of Radiation in the Target Volume Applying Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to evaluate the safety and efficacy of the stereotactic boost applied in patients with HN tumours
Detailed Description:
Aims of the study
1 Evaluation of the efficacy of the stereotactic boost applied in patients with head and neck tumours
2 Evaluation of the safety of the stereotactic boost applied in patients with head and neck tumours
3 Evaluation of the influence of the stereotactic radiotherapy boost on blood parameters reflecting tumour response interleukin 6 Il-6 thymidine kinase TK Fms-related tyrosine kinase 1 sFlt-1 and normal tissue response C-reactive protein CRP
In the case of beneficial findings the stereotactic radiosurgery boost in the course of radiochemotherapy in patients with head and neck tumours will be able to replace traditional techniques of radiation and radical schemes of treatment will be possible for future development
1 Evaluation of the efficacy of the stereotactic boost applied in patients with head and neck tumours
2 Evaluation of the safety of the stereotactic boost applied in patients with head and neck tumours
3 Evaluation of the influence of the stereotactic radiotherapy boost on blood parameters reflecting tumour response interleukin 6 Il-6 thymidine kinase TK Fms-related tyrosine kinase 1 sFlt-1 and normal tissue response C-reactive protein CRP
In the case of beneficial findings the stereotactic radiosurgery boost in the course of radiochemotherapy in patients with head and neck tumours will be able to replace traditional techniques of radiation and radical schemes of treatment will be possible for future development
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None